Compliance Management White Papers & Case Studies

1. Why Biopharma Breakthroughs Aren't Moving The Market 10/20/2025

   Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.

2. Maximize Your Laboratory Efficiency 10/20/2025

   Gain insight into how labs can boost productivity by reducing downtime, minimizing errors, and increasing walk-away time through real-time insights and analytics.

3. How Can You Avoid Bioprocessing Risks When Using Cable Ties? 10/15/2025

   Cable ties in bioprocessing can cause leaks, damage, and delays. See how switching to a uniform-sealing connector can significantly improve efficiency, reduce prep time, and minimize contamination risks.

4. Calculating The ROI Of EAM/CMMS For Pharma Manufacturers And CDMOs 10/6/2025

   Learn how modern EAM and CMMS systems help pharma manufacturers reduce risk, improve compliance, and cut costs, as well as nine signs it’s time to move beyond outdated asset management practices.

5. Molecular Approaches To Streamline Cell Therapy Product Analytical Testing 9/26/2025

   Learn how rapid molecular methods of cell therapy testing like qPCR for mycoplasma, sterility, and lentiviral quantification are key to accelerating product release and timely treatment delivery.

6. A Risk-Based Approach To Plasmid DNA And mRNA Process Development 9/23/2025

   Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.

7. Pharma Company Digitizes Paper Logbooks To Increase Data Accessibility 9/18/2025

   A top pharma producer modernized its operations by digitizing paper-based logbooks. Discover how this shift supports compliance and scalability across global manufacturing environments.

8. Aggregation In Antibody-Drug Conjugates: Causes And Mitigation 9/1/2025

   Discover how early intervention in ADC development can streamline clinical progress, ensure stability and safety, and accelerate commercialization with expert guidance.

9. Time To Intensify: Taking mAb Manufacturing To The Next Level 8/19/2025

   Explore how process intensification can revolutionize monoclonal antibody manufacturing to boost productivity, cut costs, and enhance sustainability with scalable strategies and real-world results.

10. Validation Provider Shortens The Path To Equipment Qualification 8/19/2025

    Explore the partnership enabling Transcat to meet regulatory requirements while focusing on core R&D and accelerating the delivery of life-changing therapies.